Based On Clinical Studies, "lung And Large Intestine" Theoretical Guidance Phlegm-dampness Treatment Of Lung Cancer

Objectives: Through clinical trials, observation and evaluation in the "Lung and Large Intestine" from intestinal cancer clinical efficacy of phlegm dampness from the lungs and under the theoretical guidance. Investigate the treatment of lung phlegm dampness, in order to provide clinical medicine therapy can be based on law and the theoretical basis for the treatment of lung phlegm dampness.Methods: Random number table of cases included in the study criteria, were randomly divided into two groups: the treatment group, 29 cases, 30 cases in the control group. Treatment group taking Dachengqitang subtraction and conventional symptomatic treatment and control group I Qingjin phlegm decoction and conventional symptomatic treatment, both groups 7 days for a course of treatment, two courses of treatment. TCM symptom scores before and after treatment were compared two groups of patients, white blood cell count, C- reactive protein and KPS score changes and other related indicators.Results: The subject of clinical study results are as follows:(1) the treatment group, the total efficiency of 93.33% in the control group, the total efficiency of 89.66%, no significant difference in the treatment group and the control group(P>0.05).(2) There were significant differences between the two groups before the TCM compares total score compared with treatment(P<0.05), but no total score of the TCM treatment group and control group after treatment, significant differences(P>0.05); In the ease shortness of breath, upset, big, urine and other indicators of symptoms, compared with the control group, the treatment group than in the control group(P<0.05).(3) Significantly decreased white blood cell count, neutrophil count, the percentage of neutrophils and C- reactive protein after treatment than before treatment(P<0.05); After treatment, the white blood cell count, neutrophil count, the percentage ofneutrophils and C- reactive protein was no significant difference(P>0.05).(4) After treatment, patients can improve Karnofsky, with statistical significance(P<0.05); After treatment, KPS score was no significant difference(P>0.05).(5) The safety assessment: two groups during treatment was well tolerated, serious adverse events did not appear; before and after treatment in the general indicators and safety indicators(electrocardiogram, liver and kidney function), etc. were not detected an error.Conclusion: The issue of "Lung and Large Intestine" for the treatment of lung cancer from the bowel phlegm-dampness on the theoretical basis, but this idea is the innovation of this study; the results of this research project under the guidance of this theory show: 1. From the intestine and collaboration from the lungs conventional symptomatic treatment, improve lung phlegm dampness in patients with clinical symptoms and signs, and reduce the total number of white blood cells, respect Creactive protein and improve the quality of life of patients and so have an equal effect, the basic theory from lung and Large Intestine, by making evil dismount from the intestine out of the lungs, and thus accessible organs of air, reach Xiere phlegm, chest lower gas Relaxing effect. 2. From the intestinal clinical effect is significant, no adverse reactions, for the treatment of lung phlegm dampness from the intestine to provide an effective method of clinical evidence, and to provide new treatments for lung phlegm dampness.